Timothy S. Ernst - 28 Feb 2024 Form 4 Insider Report for BIO-RAD LABORATORIES, INC. (BIO)

Role
EVP, General Counsel & Sec
Signature
/s/ Timothy S. Ernst
Issuer symbol
BIO
Transactions as of
28 Feb 2024
Net transactions value
-$11,000
Form type
4
Filing time
29 Feb 2024, 17:24:05 UTC
Previous filing
06 Sep 2023
Next filing
12 Mar 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BIO BIOB Bio-Rad A Common Stock Options Exercise $815,375 +2,500 +74% $326.15 5,897 28 Feb 2024 Direct F1
transaction BIO BIOB Bio-Rad A Common Stock Sale $826,375 -2,500 -42% $330.55 3,397 28 Feb 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BIO BIOB Non-Qualified Stock Option (right to buy) Options Exercise $0 -2,500 -100% $0.000000* 0 28 Feb 2024 Bio-Rad A Common Stock 2,500 $326.15 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 13.6810 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 09/29/2023.
F2 The option, representing a right to purchase a total of 2,500 shares, became exercisable in five equal annual installments beginning on September 4, 2019, which was the first anniversary of the date on which the option was granted.